Viewing Study NCT00502905

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:32 AM
Ignite Modification Date: 2026-02-25 @ 2:42 AM
Study NCT ID: NCT00502905
Status: COMPLETED
Last Update Posted: 2012-05-28
First Post: 2007-07-16
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Busulfan and Fludarabine in Patients With AML and MDS
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Acute Myeloid Leukemia View
None Myelodysplastic Syndromes View
None Busulfan View
None Busulfex View
None Myleran View
None Fludarabine View
None Fludarabine Phosphate View
None Fludara View